Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

RVP stock opened at $0.80 on Monday. The company has a market capitalization of $23.87 million, a P/E ratio of -1.48 and a beta of 1.94. The company has a fifty day moving average price of $0.66 and a 200-day moving average price of $0.86. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the SEC. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.